Updated:
Sonde Health
Sonde Health is a health technology company founded in 2015 in Boston, Massachusetts. It develops a vocal biomarker platform analyzing voice data for mental,...
Sonde Health
Sonde Health is a health technology company founded in 2015 in Boston, Massachusetts. It develops a vocal biomarker platform analyzing voice data for mental, cognitive, and respiratory health information. The company works with organizations to implement early detection and monitoring of health conditions.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Sector focus
Frequently asked questions
Who leads investment decisions at Sonde Health?
Sonde Health is led by CEO David Liu, who oversees the company's strategic direction. The firm has not disclosed a separate CIO or investment committee given its focus on product development rather than capital management.
How does Sonde Health generate revenue?
Sonde Health licenses its voice biomarker software development kit to healthcare organizations, insurers, and telehealth platforms. It does not sell a consumer app or charge patients directly.
How does Sonde Health differentiate from other vocal biomarker startups?
Sonde Health has built a proprietary database of millions of labeled voice samples across multiple languages and populations, which it uses to train its AI models. The firm licenses its SDK rather than building consumer products, positioning it as infrastructure for healthcare providers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: